Tag: Generics

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.

Aurobindo Pharma strengthens its European business

Aurobindo Pharma announced the signing of a definitive agreement to acquire from Apotex International, its commercial operations and certain supporting infrastructure in five European countries.

Sanofi and Advent completed negotiations for the acquisition of Zentiva

Sanofi and Advent International have finished negotiations for the acquisition of Zentiva, Sanofi's European generics business, by Advent and the companies have signed a Share Purchase Agreement worth €1.9 billion

Russia is ready to supply insulin to Bulgaria

Parallel export of drugs which, for some medicines, reached more than 20%, has created serious problems for diabetics. Russia is ready to fill the shortage and start exporting insulin to Bulgaria.

Russia is expected to simplify the registration of a dosage form

The state registration of generic drugs in the form of concentrates for solutions will no longer require a report on bioequivalence studies. A relevant draft law was adopted by the Russian State Duma in the first reading.

Swiss pharma companies are suspected of hampering generics development

The United States Food and Drug Administration published a list of pharmaceutical companies, all of which are suspected of hindering the development of generic versions of their own medicines.

Glenmark Pharma launched its asthma drug generic in Denmark

Glenmark Pharmaceuticals Europe has launched a generic version of Seretide Accuhaler, used to treat asthma, in Denmark. The product was developed by Celon Pharma.

Lannett bought portfolio of generic products from Endo International

Lannett Company announced that it has acquired 23 approved and one pending drug product applications from a subsidiary of Endo International for an upfront payment plus future milestone payments. T...

Alvogen received European approval for generic Lenalidomide

Alvogen announced that it has successfully concluded multiple registration procedures for Lenalidomide capsules. Alvogen received regulatory clearance for its product in several European countries.

Advent International will acquire Sanofi’s generics subsidiary Zentiva

Advent International and Sanofi have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi’s European generics business for €1,919 million.

Pfizer drug Champix will meet generic rivals in South Korea

South Korean drugmakers are rushing to roll out generic copies of Pfizer’s smoking cessation drug Champix, as the treatment’s substance patent here was recently broken by a local patent court.

China stimulates the research and development of generics

With support in research and development, registration of Chinese generic drugs and marketing of the drugs in the global market, companies will be encouraged by the government to carry out international cooperation.

Sun Pharma obtained FDA approval for its biologics drug

sun pharma
Sun Pharma announced that the U.S. FDA has approved its biologics drug Ilumya (Tildrakizumab) for the treatment of adults with moderate-to-severe plaque psoriasis.

Japan saved $12.2 billion through use of generics

Japan's Ministry of Health, Labour and Welfare (MHLW) suggested that the country's push to lower prescription costs by switching to generic drugs is forecast to have saved $12.2 billion in fiscal 2017.

DSM Sinochem Pharmaceuticals launches Rosuvastatin in Western Europe

DSM Sinochem Pharmaceuticals
DSM Sinochem Pharmaceuticals has successfully launched its fully backward integrated, generic Rosuvastatin drug product in multiple Western European countries

FAS will support Russian manufacturers in the registration of prices

The head of Federal Antimonopoly Service of Russia Igor Artemyev met with the executives of Pharmstandard PJSC and BIOCAD CJSC

Teva undertakes a restructuring process

Teva Pharmaceutical Industries Ltd. announced a new organization and leadership structure aimed to achieve better commercial focus and drive value creation